| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 01/02/2008 | CN101098623A Application of antioxidant for gene adjustment |
| 01/02/2008 | CN101096684A Zinc finger protein DPZF gene knock-out mice model and its usage |
| 01/02/2008 | CN101096671A Blood vessel formation inhibitor HM-X and its preparation method and application |
| 01/02/2008 | CN101096664A Arginine deacylase covalent ornaments, its manufacturing method and application |
| 01/02/2008 | CN101096654A Method for proliferating human hemapoietic stem cell and progenitor cell by GST-hDSL recombinant protein |
| 01/02/2008 | CN101096386A Dectin-1 and heat shock protein Hsp60 polymer and coding nucleic acid and application thereof |
| 01/02/2008 | CN101096385A Preparation method of fused protein for antioxidation and preventing diabetes and application thereof |
| 01/02/2008 | CN101096384A Preparation method of fused protein for antitumor and application thereof |
| 01/02/2008 | CN101096382A Aglyco products and methods of use |
| 01/02/2008 | CN101095953A Treating cancer through attracting effect T cell and loss regulating T cell |
| 01/02/2008 | CN101095952A Treatment of fungal infections with polyene or beta glucan synthase inhibitor antifungals combined with anti HSP90 antibodies |
| 01/02/2008 | CN101095948A Use of ulinastain in the preparing of treating and/or preventing sudden arrest of heart beat tritocerebrum damnification medicine |
| 01/02/2008 | CN101095947A Multilevel bionic melissa powder and the preparations thereof and the method for preparing the same |
| 01/02/2008 | CN101095946A Anti-drug liquor for giving up drug-taking and method for preparing the same |
| 01/02/2008 | CN101095945A Fibre connexin active tears and production method thereof |
| 01/02/2008 | CN101095944A Sustained-releasing paster for preventing and treating prostatitis acupuncture points and the method for preparing the same and the use thereof |
| 01/02/2008 | CN101095943A Compound recipe human body bone component extender |
| 01/02/2008 | CN101095942A Formulation of the Exendin injection medicine containing stabilizing agent |
| 01/02/2008 | CN101095941A Novel use of leuprorelin acetate in the preventing and treating of osteoporosis |
| 01/02/2008 | CN101095697A Extractive of bdella and/or lumbricus with the molecular weight below 5800 dalton |
| 01/02/2008 | CN101095675A Dipeptidyl peptidase IV effectors |
| 01/02/2008 | CN101095665A Use of SIRT1 in the preventing, controlling and treating of fatness |
| 01/02/2008 | CN100359015C Human tumour-derived polyptde hormone phosphatonin |
| 01/02/2008 | CN100358920C Methods for identifying inducers and inhibitors of propteolytic antibodies, compositions and their uses |
| 01/02/2008 | CN100358919C Mammal prolactin variants |
| 01/02/2008 | CN100358917C Tumor tag and the use thereof |
| 01/02/2008 | CN100358901C Cross-linked glycopeptide-cephalosporin antibiotics |
| 01/02/2008 | CN100358579C Compositions and methods to improve oral absorption of antimicrobial agents |
| 01/02/2008 | CN100358494C Inhalation system |
| 01/01/2008 | US7314925 Vectors comprise avian lysozyme leader peptide for targetting the endoplasmic reticulum; heparin affinity chromatography |
| 01/01/2008 | US7314921 Cysteine variants of erythropoietin |
| 01/01/2008 | US7314920 Antibodies against the PRO4340 polypeptide |
| 01/01/2008 | US7314917 Modified vitamin K-dependent polypeptides |
| 01/01/2008 | US7314914 Nucleotide sequences coding polypeptide for use in the treatment of cancer and nervous system disorders |
| 01/01/2008 | US7314911 Prostate hyperplasia therapy |
| 01/01/2008 | US7314888 2-{5-[(2,4-diisobutoxyphenyl)(hydroxy)methyl]-2-isobutoxyphenyl}-acetic acid; inhibits the activity of transcription factor AP-1 |
| 01/01/2008 | US7314869 Vaccine vector comprising isolated nucleic acid molecule which encodes sequence 2 linked to promoter |
| 01/01/2008 | US7314868 fusing cells; nucleic acid vector comprises a nucleotide sequence encoding a measles virus F glycoprotein and a nucleotide sequence encoding a chimeric measles virus H glycoprotein; nucleotide sequence encoding a syncytium-inducing polypeptide expressible on a eukaryotic cell surface |
| 01/01/2008 | US7314867 Pharmaceutical composition comprising a retro-iverso isomer peptide |
| 01/01/2008 | US7314866 designing a peptide or chemical to mimic the Bax-suppressing function of VPMLKE, VPMLK, PMLKE or PMLK; apoptosis resistance |
| 01/01/2008 | US7314865 inducing lypolysis using a nucleic acid expression vector coding for an insect adipokinetic hormone polypeptide; cyclization and amidation; dietetics; drug screening |
| 01/01/2008 | US7314864 Isolated polypeptid of 24-amino acids; the clone suppressed neuronal death induced by all of the known types of early-onset familial Altzheimers Disease genes |
| 01/01/2008 | US7314863 Administering cyclic peptides; arthritis, inflammations, osteoporosis, retinopathies, contraception |
| 01/01/2008 | US7314862 Antitumor agent |
| 01/01/2008 | US7314861 For increasing appetite in a subject, for research |
| 01/01/2008 | US7314860 Heparin-like compounds, their preparation and use to prevent arterial thrombosis associated with vascular injury and interventions |
| 01/01/2008 | US7314859 Administering glucagon daily as part of a diabetes treatment regimen |
| 01/01/2008 | US7314858 Isolated polypeptide; nonhemolytic, minimal in vitro cytotoxicity |
| 01/01/2008 | US7314857 Synergistic antimicrobial compositions and methods of inhibiting biofilm formation |
| 01/01/2008 | US7314856 Adrenomedullin agonists |
| 01/01/2008 | US7314855 Inhibition of ATF2 activity to treat cancer |
| 01/01/2008 | US7314760 Using invasive trophoblastic antigen (ITA) and human chorionic gonadotropin (hCG) isoform concentration as diagnostic indicators of chromosomal abnormalities which lead to downe's syndrome; pregnancy screening |
| 01/01/2008 | US7314754 Polynucleotide encoding the hOT7T175 G protein coupled receptor |
| 01/01/2008 | US7314753 Cytoplasmic expression of antibodies, antibody fragments and antibody fragment fusion proteins in E. coli |
| 01/01/2008 | US7314742 Immunoassay diagnosis of susceptibility to atherosclerosis by analyzing blood for presence of enzyme using polyclonal or monoclonal antibodies; elevated levels are indicative of susceptibility |
| 01/01/2008 | US7314734 Muteins of placental growth factor type 1, preparation method and application thereof |
| 01/01/2008 | US7314733 Nucleotide sequences coding tau protein for use as diagnostic tool in detection of alzheimer's and neurodegenerative disorders |
| 01/01/2008 | US7314730 Identifying modulator which inhibit membrane bound protease activity for use in treatment and prevention of atherosclerosis, infections, inflammation, cell proliferative, neurodegenerative and respiratory system disorders |
| 01/01/2008 | US7314728 Methods of treating peripheral arterial occlusions |
| 01/01/2008 | US7314724 Therapeutic applications of laminin and laminin-derived protein fragments |
| 01/01/2008 | US7314721 Autologous antibody screening; indication of regression, progression or onset |
| 01/01/2008 | US7314633 Carboxylate-gated-nitroxide (CGN) compounds and compositions and methods of use thereof |
| 01/01/2008 | US7314626 Peptide antibiotic conjugate for use in recognition and elimination of infections agents or neoplasms; antitumor agents; bactericides |
| 01/01/2008 | US7314625 Generating polyclonal antisera that reduce adherence of the microorganism expressing the Type IV pilin loop sequence to the epithelial cells |
| 01/01/2008 | US7314623 Methods and compositions for modulating T helper (Th) cell development and function |
| 01/01/2008 | US7314618 Novel nucleic acids encoding a fibroblast growth factor-23(FGF23) and proteins encoded thereby, mutations in which are associated with autosomal dominant rickets (ADHR). The invention further relates to methods of diagnosis of |
| 01/01/2008 | US7314617 Platelet rich plasma, no exogenous activator; sodium bicarbonate buffer, citrate dextrose anticoagulant |
| 01/01/2008 | US7314615 IκB Kinase-β (IKKβ) binding antibodies and methods of using same |
| 01/01/2008 | US7314613 Covalently attached to a nonpeptide moiety; nucleic acids encoding the polypeptides; reducing the number of copies of a virus in infected cells |
| 12/27/2007 | WO2007150053A2 Composition and method for delivery of bmp-2 amplifier/co-activator for enhancement of osteogenesis |
| 12/27/2007 | WO2007150049A2 Lactoferrin as a radioprotective agent |
| 12/27/2007 | WO2007150046A2 Methods and compositions for treating ophthalmic conditions via modulation of megalin activity |
| 12/27/2007 | WO2007149938A2 Methods for promoting hair growth |
| 12/27/2007 | WO2007149935A2 Methods and compositions for modulating hepsin activation of urokinase-type plasminogen activator |
| 12/27/2007 | WO2007149875A2 Compositions and methods for treating, preventing and/or reversing type-1 diabetes |
| 12/27/2007 | WO2007149827A2 Method for modulating the pharmacokinetics and metabolism of a therapeutic agent |
| 12/27/2007 | WO2007149814A1 Methods of modulating il-22 and il-17 |
| 12/27/2007 | WO2007149594A2 Modified ribonucleases |
| 12/27/2007 | WO2007149512A2 Peptide epoxyketones for pr0teas0me inhibition |
| 12/27/2007 | WO2007149406A2 Modified coagulation factor ix polypeptides and use thereof for treatment |
| 12/27/2007 | WO2007149382A2 Therapeutic compositions and methods useful in treating hepatitis |
| 12/27/2007 | WO2007149381A2 Compositions comprising a ptp-ase inhibitor and use thereof in treating cancer |
| 12/27/2007 | WO2007149343A2 Proteases for treatment of venomous bites |
| 12/27/2007 | WO2007149288A2 C1-inhibitor prevents non-specific plasminogen activation by a prourokinase mutant without impeding fibrin-specific fibrinolysis |
| 12/27/2007 | WO2007149141A2 C1-inactivator inhibits two-chain urokinase mutant and limits hemostatic bleeding during thromolysis |
| 12/27/2007 | WO2007149119A1 Water stabilized aerosol formulation system and method of making |
| 12/27/2007 | WO2007149096A1 Stabilizing alkylglycoside compositions and methods thereof |
| 12/27/2007 | WO2007149052A1 Novel polypeptides for anti-viral treatment |
| 12/27/2007 | WO2007148951A1 Process for the production of bromelain by means of substances that induce proteins in pineapple plants |
| 12/27/2007 | WO2007148837A1 Composition capable of promoting the production of collagen |
| 12/27/2007 | WO2007148804A1 Composition capable of promoting the production of hyaluronic acid |
| 12/27/2007 | WO2007148803A1 Composition capable of promoting the production of hyaluronic acid |
| 12/27/2007 | WO2007148609A1 Ex vivo/in vivo proliferation of hematopoietic stem cell or hematopoietic progenitor cell by timp-3 |
| 12/27/2007 | WO2007148488A1 Peptide for reactivation of inactivated gene |
| 12/27/2007 | WO2007148317A1 Mcp-1 splice variants and methods of using same |
| 12/27/2007 | WO2007148307A1 Compositions and kits comprising a melatonin component and a chondroprotective component |
| 12/27/2007 | WO2007148135A1 Macrocyclic compounds as antiviral agents |
| 12/27/2007 | WO2007148078A1 Use cathelicidin antimicrobial protein (hcap18 ) as anticancer agent |
| 12/27/2007 | WO2007147945A1 Modified beta-lactamase and method for its preparation |
| 12/27/2007 | WO2007147898A1 Soluble heterodimeric receptors and uses thereof |